Skip Nav Destination
Issues
1 January 2019
-
Cover Image
Cover Image
ABOUT THE COVER
In this issue, Manca and colleagues (beginning on page 225) demonstrate for the first time the molecular link between alcohol consumption and the progression of prostate cancer. Using both human tissue, from non-alcoholic or alcoholic patients, and ethanol-fed animals, the authors demonstrate that ethanol is able to enhance the proliferation of prostate cancer cells and their metastatic potential. Specifically, they found that ethanol-induced Golgi fragmentation is associated with the relocation of glycogen synthase kinase β (GSK3β) from Golgi to the cytoplasm, thus activating the HDAC6-HSP90-AR pathway. The cover image shows that the fluorescence signal of GSK3β (red) segregated from Golgi membranes (stained by giantin, green) in the tissue section from a patient with prostate adenocarcinoma (Gleason 10). - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1541-7786
EISSN 1557-3125
Journal Archive
Molecular Cancer Research (2002-Present; volumes 1-current)
(ISSN 0008-5472) Published monthly since November, 2002.Cell Growth & Differentiation (1990-2002; volumes 1-13)
(ISSN 1044-9523) Published monthly 1990- September, 2002.Table of Contents
Highlights
Perspective
Cell Cycle and Senescence
Cell Death and Survival
Chromatin, Epigenetics, and RNA Regulation
Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression
Thomas J. Rogers; Jessica L. Christenson; Lisa I. Greene; Kathleen I. O'Neill; Michelle M. Williams; Michael A. Gordon; Travis Nemkov; Angelo D'Alessandro; Greg D. Degala; Jimin Shin; Aik-Choon Tan; Diana M. Cittelly; James R. Lambert; Jennifer K. Richer
DNA Damage and Repair
Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk
Ambre Petitalot; Elodie Dardillac; Eric Jacquet; Naima Nhiri; Josée Guirouilh-Barbat; Patrick Julien; Isslam Bouazzaoui; Dorine Bonte; Jean Feunteun; Jeff A. Schnell; Philippe Lafitte; Jean-Christophe Aude; Catherine Noguès; Etienne Rouleau; Rosette Lidereau; Bernard S. Lopez; Sophie Zinn-Justin; Sandrine M. Caputo; on behalf of the UNICANCER Genetic Group BRCA network
Genomics
Author Choice
Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors
Isabel Romero-Calvo; Christopher R. Weber; Mohana Ray; Miguel Brown; Kori Kirby; Rajib K. Nandi; Tiha M. Long; Samantha M. Sparrow; Andrey Ugolkov; Wenan Qiang; Yilin Zhang; Tonya Brunetti; Hedy Kindler; Jeremy P. Segal; Andrey Rzhetsky; Andrew P. Mazar; Mary M. Buschmann; Ralph Weichselbaum; Kevin Roggin; Kevin P. White
Metabolism
A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
Lisa I. Greene; Tullia C. Bruno; Jessica L. Christenson; Angelo D'Alessandro; Rachel Culp-Hill; Kathleen Torkko; Virginia F. Borges; Jill E. Slansky; Jennifer K. Richer
Oncogenes and Tumor Suppressors
Signal Transduction
Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model
Takahiro Tsuji; Hiroaki Ozasa; Wataru Aoki; Shunsuke Aburaya; Tomoko Funazo; Koh Furugaki; Yasushi Yoshimura; Hitomi Ajimizu; Ryoko Okutani; Yuto Yasuda; Takashi Nomizo; Kiyoshi Uemasu; Koichi Hasegawa; Hironori Yoshida; Yoshitaka Yagi; Hiroki Nagai; Yuichi Sakamori; Mitsuyoshi Ueda; Toyohiro Hirai; Young Hak Kim
Tumor Microenvironment and Immunobiology
A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery
Christina Schug; Aayush Gupta; Sarah Urnauer; Katja Steiger; Phyllis Fung-Yi Cheung; Christian Neander; Konstantinos Savvatakis; Kathrin A. Schmohl; Marija Trajkovic-Arsic; Nathalie Schwenk; Markus Schwaiger; Peter J. Nelson; Jens T. Siveke; Christine Spitzweg
Acknowledgment to Reviewers
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.